NAFLD Clinical Trial - An Investigational Study to Evaluate Experimental

See also
Status	Clinical Trial	Phase
Completed	`NCT06101433` - The Effect of Soy Isoflavones on Non-alcoholic Fatty Liver Disease and the Level of FGF-21 and Fetuin A	N/A
Completed	`NCT03289897` - Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan	N/A
Recruiting	`NCT05479721` - LITMUS Imaging Study
Completed	`NCT05527938` - Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Children	N/A
Recruiting	`NCT06308757` - Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis	N/A
Completed	`NCT02654977` - CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial Lipodystrophy	Phase 2
Completed	`NCT02927184` - Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease	Phase 2
Recruiting	`NCT06047847` - Determination of Biological Activity of Enriched Serum Following TOTUM-448 Consumption	N/A
Active, not recruiting	`NCT03534908` - Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: the Correlation Analysis and Risk Prediction Model Study
Recruiting	`NCT06098417` - Biomarkers in the Diagnosis and Prognosis of NAFLD
Recruiting	`NCT04564391` - Whey or Casein - Liver Fat Reduction and Metabolic Improvement by Fast vs. Slow Proteins	N/A
Not yet recruiting	`NCT05984745` - Effect of CoQ10 on the Outcome of MAFLD Patients	Phase 2
Not yet recruiting	`NCT05052515` - The Effects of Natural Extracts Supplementation on NASH Patients	N/A
Recruiting	`NCT02459496` - Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus	N/A
Completed	`NCT01936779` - Understanding the Role of Dietary Fatty Acids on Liver Fat Metabolism in Humans	N/A
Completed	`NCT05844137` - Improving Detection and Evidence-based Care of NAFLD in Latinx and Black Patients With Type 2 Diabetes	N/A
Recruiting	`NCT04664036` - Prevalence, Incidence and Characteristics of NAFLD/NASH in Type 1 Diabetes Mellitus
Recruiting	`NCT04976283` - Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver	Phase 4
Recruiting	`NCT03587298` - Use of Shear Wave Elastography to Assess Non-alcoholic Fatty Liver Disease (NAFLD)
Completed	`NCT02952170` - Impact of Weight Loss Surgery in Adolescents With NAFLD	N/A

NCT number	NCT03674476
Study type	Interventional
Source	Bristol-Myers Squibb
Contact
Status	Completed
Phase	Phase 1
Start date	September 11, 2018
Completion date	June 24, 2019

An Investigational Study to Evaluate Experimental Medication BMS-986036 in Participants With Different Levels of Kidney Function

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms